Real-world starting dose and outcomes of palbociclib plus an aromatase inhibitor for metastatic breast cancer. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results